Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 0.70 INR
Change Today +0.01 / 1.45%
Volume 800.0
MAVB On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

mavens biotech ltd (MAVB) Snapshot

Open
0.70
Previous Close
0.69
Day High
0.70
Day Low
0.70
52 Week High
07/4/14 - 1.81
52 Week Low
01/12/15 - 0.51
Market Cap
76.9M
Average Volume 10 Days
840.7
EPS TTM
0.01
Shares Outstanding
109.9M
EX-Date
09/16/10
P/E TM
70.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for MAVENS BIOTECH LTD (MAVB)

Related News

No related news articles were found.

mavens biotech ltd (MAVB) Related Businessweek News

No Related Businessweek News Found

mavens biotech ltd (MAVB) Details

Mavens Biotech Limited operates as a agro-biotech company in India. The company primarily trades in agro products and commodities, such as cotton, vegetable products, etc. It is also involved in IT activities. The company was incorporated in 1981 and is based in Kolkata, India.

Founded in 1981

mavens biotech ltd (MAVB) Top Compensated Officers

Whole Time Director
Total Annual Compensation: 252.0K
Compensation as of Fiscal Year 2014.

mavens biotech ltd (MAVB) Key Developments

Mavens Biotech Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Mavens Biotech Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company’s total income from operations (net) was INR 2.302 million compared to INR 93.16 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 0.15 million compared to INR 0.50 million a year ago. Profit from ordinary activities before tax was INR 0.41 million compared to INR 0.78 million a year ago. Net profit for the period was INR 0.41 million or INR 0.004 per basic and diluted share, compared to INR 0.78 million or INR 0.007 per basic and diluted share, a year ago. For the year to date, the company’s total income from operations (net) was INR 6.59 million compared to INR 309.77 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 0.36 million compared to INR 2.3 million a year ago. Profit from ordinary activities before tax was INR 1.15 million compared to INR 3.11 million a year ago. Net profit for the period was INR 1.15 million or INR 0.010 per basic and diluted share, compared to INR 3.11 million or INR 0.028 per basic and diluted share, a year ago.

Mavens Biotech Limited, Board Meeting, Feb 11, 2015

Mavens Biotech Limited, Board Meeting, Feb 11, 2015. Agenda: To consider unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014.

Mavens Biotech Limited Approves Address Change

Mavens Biotech Ltd. announced that the Board of Directors of the company at its meeting held on January 05, 2015, has passed the resolution for shifting of its registered office to Room No-407, 4th floor No - 4 Clive Row,Kolkata -700001 for better accommodation with effect from January 05, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MAVB:IN 0.70 INR +0.01

MAVB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MAVB.
View Industry Companies
 

Industry Analysis

MAVB

Industry Average

Valuation MAVB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.9x
Price/Book 0.4x
Price/Cash Flow 132.0x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAVENS BIOTECH LTD, please visit www.mavensbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.